October 20, 2016
IDIBAPS participates in the creation of the first international criteria for the diagnosis of IgG4 disease
IgG4 is a subclass of immunoglobulin G that represents only between 3 and 6% of total serum immunoglobulin G and is involved in a broad spectrum of clinical entities. This entities usually are characterized by an inflammatory reaction, alone or as a diffuse mass, single or multiple, affecting exocrine glands, lymph nodes or extranodal tissue. IgG4 related disease has an autoimmune basis and was described only ten years ago. The diversity in clinical presentation makes diagnosis is very complex.
October 19, 2016
Joan Clària, head of the Inflammation on liver disease research group at IDIBAPS-Clínic, has been one of the winners of the Albus awards, given annually by the company Grifols. With an endowment of 50,000 euros, the award promotes research on albumin as a therapeutic product.
October 17, 2016
The Board of Governors of IDIBAPS has begun the process to select a new director of the institute, in replacement of Ramon Gomis. Gomis, endocrinologist expert in diabetes, has been at the forefront of the institution since 2008. Among others, candidates who wish to apply for the postition must have a relevant curriculum in the field of biomedical research , as well as expertise in management, planning and resource allocation. You can find the detailed application here. The application deadline is next 30 November 2016.
October 13, 2016The distribution of the "Handbook of Translational Medicine” began last week. Dr. Josep M. Llovet, ICREA professor at IDIBAPS-Hospital Clínic and director of the Master in Translational Medicine at the University of Barcelona, is the manual’s editor and several professionals from Clínic Campus have collaborated. The aim of the book is to summarize the basic concepts of translational medicine, defined as the discipline that transfers the knowledge and discoveries generated by basic research in biomedical sciences into clinical practice.
October 10, 2016
From 28 to 30 September was held in Bilbao the 8th edition of BioSpain, a meeting that involves pharma and biotech companies and organizations. BioSpain provides a space for identifying potential partners and lectures, presentations of companies, investment forums are made, and provides a forum for training and work. In this edition 615 companies have participated, 30% of which are international. The Catalan delegation has had the participation of 90companies and public institutions.